Contact Information
Call us at: (614) 722-4766
Fax us at: (614) 722-4755
PediatricsPulmonary Medicine700 Children’s DrColumbus, OH 43205 (map)
Learn more about Karen S. McCoy
Biography
Karen S. McCoy, MD, is chief of the Division of Pulmonary Medicine at Nationwide Children’s Hospital, Nationwide Foundation Endowed Chair in Pulmonary Medicine and professor of Pediatrics at The Ohio State University College of Medicine. Her clinical interests focus on managing patients of all ages with cystic fibrosis (CF) and pediatric asthma. Dr. McCoy’s research interests revolve around clinical outcomes and trials in cystic fibrosis and asthma. She is the principal investigator for the CF Therapeutic Development Center. She is the director of the CF Center, and medical director for Infant and Non-infant Pulmonary Function, and Respiratory Care.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Academic and Clinical Areas
Cystic Fibrosis
Chief
Pulmonary Medicine
Division Chief
Advanced Lung Disease
Physician Team
Neuromuscular Disorders
Physician Team
Jeune’s Syndrome
Physician Team
Asthma Program
Physician Team
Pediatric Pulmonary Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Pulmonary, Sleep Medicine and Cystic Fibrosis
Awards, Honors & Organizations
Career Contribution Award Recipient, Nationwide Children’s Hospital, 2018 Golden Stethoscope Award Recipient, Nationwide Children’s Hospital, 2012 Listed, Best Doctors in America
Research
Publications
Sheikh S, Britt RD Jr, Ryan-Wenger NA, Khan AQ, Lewis BW, Gushue C, Ozuna H, Jaganathan D, McCoy K, Kopp BT. Impact of Elexacaftor-Tezacaftor-Ivacaftor on Bacterial Colonization and Inflammatory Responses in Cystic Fibrosis. Pediatr Pulmonol. 2022 Nov 29;
Zhang S, Shrestha CL, Robledo-Avila F, Jaganathan D, Wisniewski BL, Brown N, Pham H, Carey K, Amer AO, Hall-Stoodley L, McCoy KS, Bai S, Partida-Sanchez S, Kopp BT. Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor. Eur Respir J. 2022 Oct 20;
Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;
Hall-Stoodley L, McCoy KS. Biofilm aggregates and the host airway-microbial interface. Front Cell Infect Microbiol. 2022; 12: 969326.
Huang Y, Paul G, Lee J, Yarlagadda S, McCoy K, Naren AP. Elexacaftor/Tezacaftor/Ivacaftor Improved Clinical Outcomes in a Patient with N1303K-CFTR Based on In Vitro Experimental Evidence. Am J Respir Crit Care Med. 2021 Nov 15; 204: 1231-1235.
Paul GR, Bai S, Jackson K, McCoy KS. Aquagenic wrinkling in children under two years of age: Could this be a potential clinical referral tool for cystic fibrosis among non-screened populations? J Cyst Fibros. 2021 Sep; 20: e77-e83.
Wang H, Diaz A, Moyer K, Mele-Casas M, Ara-Montojo MF, Torrus I, McCoy K, Mejias A, Leber AL. Molecular and Clinical Comparison of Enterovirus D68 Outbreaks among Hospitalized Children, Ohio, USA, 2014 and 2018. Emerg Infect Dis. 2019 Nov 17; 25:
Schuler CL, Biagini Myers JM, Kercsmar CM, Pilipenko VV, Kroner JW, Simmons JM, Austin SR, Gunkelman SM, Ross KR, McCoy KS, Kalra M, Ruddy JR, Martin LJ, Khurana Hershey GK. Weighing in on asthma: Insights on BMI, magnesium, and hospitalizations from the Ohio Pediatric Asthma Repository. J Asthma. 2019 Aug 14; 1-8.
Goetz D, Kopp BT, Salvator A, Moore-Clingenpeel M, McCoy K, Leung DH, Kloster M, Ramsey BR, Heltshe SH, Borowitz D. Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study. Pediatr Pulmonol. 2019 May; 54: 581-586.
Sagel SD, Khan U, Jain R, Graff G, Daines CL, Dunitz JM, Borowitz D, Orenstein DM, Abdulhamid I, Noe J, Clancy JP, Slovis B, Rock MJ, McCoy KS, Strausbaugh S, Livingston FR, Papas KA, Shaffer ML. Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial. Am J Respir Crit Care Med. 2018 Sep 1; 198: 639-647.
Clary G, Sasindran SJ, Nesbitt N, Mason L, Cole S, Azad A, McCoy K, Schlesinger LS, Hall-Stoodley L. Mycobacterium abscessus Smooth and Rough Morphotypes Form Antimicrobial-Tolerant Biofilm Phenotypes but Are Killed by Acetic Acid. Antimicrob Agents Chemother. 2018 Mar; 62:
Shein SL, Farhan O, Morris N, Mahmood N, Alter SJ, Biagini Myers JM, Gunkelman SM, Kercsmar CM, Khurana Hershey GK, Martin LJ, McCoy KS, Ruddy JR, Ross KR. Adjunctive Pharmacotherapies in Children With Asthma Exacerbations Requiring Continuous Albuterol Therapy: Findings From The Ohio Pediatric Asthma Repository. Hosp Pediatr. 2018 Jan 5;
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 02/16/1988
Board Certifications
Pediatric Pulmonary Medicine Pediatrics
Fellowship
Arizona Health Science Center
Date Completed: 06/30/1982
Residency
North Carolina Memorial Hospital
Date Completed: 06/30/1979
Medical School
University of North Carolina
Date Completed: 12/31/1975
Professional Experience
1995 - Present Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children’s Hospita, Associate Professor of Pediatrics1987 - 1995 Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children’s Hospital, Asst. Prof Pediatrics1985 - 1987 Division of Pulmonary Disease/Cystic Fibrosis Regional Center, University of Florida College of Medicine, Asst. Prof Pediatrics1982 - 1984 OSU College of Medicine and Medical Director of Respiratory Care and Pulmonary Functions, Children’s Hospital, Asst. Prof Pediatrics1979 - 1982 Arizona Health Science Center, Fellowship Ped. Pulmonary Disease1977 - 1979 NC Memorial Hospital, Residency Pediatrics1976 - 1977 NC Memorial Hospital, Internship Pediatrics
Contact Information
Pediatrics
Call us at: (614) 722-4766
Fax us at: (614) 722-4755
Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-4766
Fax us at: (614) 722-4755
PediatricsPulmonary Medicine700 Children’s DrColumbus, OH 43205 (map)
Learn more about Karen S. McCoy
Biography
Karen S. McCoy, MD, is chief of the Division of Pulmonary Medicine at Nationwide Children’s Hospital, Nationwide Foundation Endowed Chair in Pulmonary Medicine and professor of Pediatrics at The Ohio State University College of Medicine. Her clinical interests focus on managing patients of all ages with cystic fibrosis (CF) and pediatric asthma. Dr. McCoy’s research interests revolve around clinical outcomes and trials in cystic fibrosis and asthma. She is the principal investigator for the CF Therapeutic Development Center. She is the director of the CF Center, and medical director for Infant and Non-infant Pulmonary Function, and Respiratory Care.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Academic and Clinical Areas
Cystic Fibrosis
Chief
Pulmonary Medicine
Division Chief
Advanced Lung Disease
Physician Team
Neuromuscular Disorders
Physician Team
Jeune’s Syndrome
Physician Team
Asthma Program
Physician Team
Pediatric Pulmonary Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Pulmonary, Sleep Medicine and Cystic Fibrosis
Awards, Honors & Organizations
Career Contribution Award Recipient, Nationwide Children’s Hospital, 2018 Golden Stethoscope Award Recipient, Nationwide Children’s Hospital, 2012 Listed, Best Doctors in America
Research
Publications
Sheikh S, Britt RD Jr, Ryan-Wenger NA, Khan AQ, Lewis BW, Gushue C, Ozuna H, Jaganathan D, McCoy K, Kopp BT. Impact of Elexacaftor-Tezacaftor-Ivacaftor on Bacterial Colonization and Inflammatory Responses in Cystic Fibrosis. Pediatr Pulmonol. 2022 Nov 29;
Zhang S, Shrestha CL, Robledo-Avila F, Jaganathan D, Wisniewski BL, Brown N, Pham H, Carey K, Amer AO, Hall-Stoodley L, McCoy KS, Bai S, Partida-Sanchez S, Kopp BT. Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor. Eur Respir J. 2022 Oct 20;
Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;
Hall-Stoodley L, McCoy KS. Biofilm aggregates and the host airway-microbial interface. Front Cell Infect Microbiol. 2022; 12: 969326.
Huang Y, Paul G, Lee J, Yarlagadda S, McCoy K, Naren AP. Elexacaftor/Tezacaftor/Ivacaftor Improved Clinical Outcomes in a Patient with N1303K-CFTR Based on In Vitro Experimental Evidence. Am J Respir Crit Care Med. 2021 Nov 15; 204: 1231-1235.
Paul GR, Bai S, Jackson K, McCoy KS. Aquagenic wrinkling in children under two years of age: Could this be a potential clinical referral tool for cystic fibrosis among non-screened populations? J Cyst Fibros. 2021 Sep; 20: e77-e83.
Wang H, Diaz A, Moyer K, Mele-Casas M, Ara-Montojo MF, Torrus I, McCoy K, Mejias A, Leber AL. Molecular and Clinical Comparison of Enterovirus D68 Outbreaks among Hospitalized Children, Ohio, USA, 2014 and 2018. Emerg Infect Dis. 2019 Nov 17; 25:
Schuler CL, Biagini Myers JM, Kercsmar CM, Pilipenko VV, Kroner JW, Simmons JM, Austin SR, Gunkelman SM, Ross KR, McCoy KS, Kalra M, Ruddy JR, Martin LJ, Khurana Hershey GK. Weighing in on asthma: Insights on BMI, magnesium, and hospitalizations from the Ohio Pediatric Asthma Repository. J Asthma. 2019 Aug 14; 1-8.
Goetz D, Kopp BT, Salvator A, Moore-Clingenpeel M, McCoy K, Leung DH, Kloster M, Ramsey BR, Heltshe SH, Borowitz D. Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study. Pediatr Pulmonol. 2019 May; 54: 581-586.
Sagel SD, Khan U, Jain R, Graff G, Daines CL, Dunitz JM, Borowitz D, Orenstein DM, Abdulhamid I, Noe J, Clancy JP, Slovis B, Rock MJ, McCoy KS, Strausbaugh S, Livingston FR, Papas KA, Shaffer ML. Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial. Am J Respir Crit Care Med. 2018 Sep 1; 198: 639-647.
Clary G, Sasindran SJ, Nesbitt N, Mason L, Cole S, Azad A, McCoy K, Schlesinger LS, Hall-Stoodley L. Mycobacterium abscessus Smooth and Rough Morphotypes Form Antimicrobial-Tolerant Biofilm Phenotypes but Are Killed by Acetic Acid. Antimicrob Agents Chemother. 2018 Mar; 62:
Shein SL, Farhan O, Morris N, Mahmood N, Alter SJ, Biagini Myers JM, Gunkelman SM, Kercsmar CM, Khurana Hershey GK, Martin LJ, McCoy KS, Ruddy JR, Ross KR. Adjunctive Pharmacotherapies in Children With Asthma Exacerbations Requiring Continuous Albuterol Therapy: Findings From The Ohio Pediatric Asthma Repository. Hosp Pediatr. 2018 Jan 5;
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 02/16/1988
Board Certifications
Pediatric Pulmonary Medicine Pediatrics
Fellowship
Arizona Health Science Center
Date Completed: 06/30/1982
Residency
North Carolina Memorial Hospital
Date Completed: 06/30/1979
Medical School
University of North Carolina
Date Completed: 12/31/1975
Professional Experience
1995 - Present Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children’s Hospita, Associate Professor of Pediatrics1987 - 1995 Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children’s Hospital, Asst. Prof Pediatrics1985 - 1987 Division of Pulmonary Disease/Cystic Fibrosis Regional Center, University of Florida College of Medicine, Asst. Prof Pediatrics1982 - 1984 OSU College of Medicine and Medical Director of Respiratory Care and Pulmonary Functions, Children’s Hospital, Asst. Prof Pediatrics1979 - 1982 Arizona Health Science Center, Fellowship Ped. Pulmonary Disease1977 - 1979 NC Memorial Hospital, Residency Pediatrics1976 - 1977 NC Memorial Hospital, Internship Pediatrics
Contact Information
Pediatrics
Call us at: (614) 722-4766
Fax us at: (614) 722-4755
Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-4766
Fax us at: (614) 722-4755
PediatricsPulmonary Medicine700 Children’s DrColumbus, OH 43205 (map)
Learn more about Karen S. McCoy
Contact Information
- Call us at:
- (614) 722-4766
- Fax us at:
- (614) 722-4755
- PediatricsPulmonary Medicine700 Children’s DrColumbus, OH 43205 (map)
Learn more about Karen S. McCoy
Biography
Karen S. McCoy, MD, is chief of the Division of Pulmonary Medicine at Nationwide Children’s Hospital, Nationwide Foundation Endowed Chair in Pulmonary Medicine and professor of Pediatrics at The Ohio State University College of Medicine. Her clinical interests focus on managing patients of all ages with cystic fibrosis (CF) and pediatric asthma. Dr. McCoy’s research interests revolve around clinical outcomes and trials in cystic fibrosis and asthma. She is the principal investigator for the CF Therapeutic Development Center. She is the director of the CF Center, and medical director for Infant and Non-infant Pulmonary Function, and Respiratory Care.
Biography
Karen S. McCoy, MD, is chief of the Division of Pulmonary Medicine at Nationwide Children’s Hospital, Nationwide Foundation Endowed Chair in Pulmonary Medicine and professor of Pediatrics at The Ohio State University College of Medicine. Her clinical interests focus on managing patients of all ages with cystic fibrosis (CF) and pediatric asthma. Dr. McCoy’s research interests revolve around clinical outcomes and trials in cystic fibrosis and asthma. She is the principal investigator for the CF Therapeutic Development Center. She is the director of the CF Center, and medical director for Infant and Non-infant Pulmonary Function, and Respiratory Care.
Biography
Karen S. McCoy, MD, is chief of the Division of Pulmonary Medicine at Nationwide Children’s Hospital, Nationwide Foundation Endowed Chair in Pulmonary Medicine and professor of Pediatrics at The Ohio State University College of Medicine. Her clinical interests focus on managing patients of all ages with cystic fibrosis (CF) and pediatric asthma. Dr. McCoy’s research interests revolve around clinical outcomes and trials in cystic fibrosis and asthma. She is the principal investigator for the CF Therapeutic Development Center. She is the director of the CF Center, and medical director for Infant and Non-infant Pulmonary Function, and Respiratory Care.
Karen S. McCoy, MD, is chief of the Division of Pulmonary Medicine at Nationwide Children’s Hospital, Nationwide Foundation Endowed Chair in Pulmonary Medicine and professor of Pediatrics at The Ohio State University College of Medicine. Her clinical interests focus on managing patients of all ages with cystic fibrosis (CF) and pediatric asthma. Dr. McCoy’s research interests revolve around clinical outcomes and trials in cystic fibrosis and asthma. She is the principal investigator for the CF Therapeutic Development Center. She is the director of the CF Center, and medical director for Infant and Non-infant Pulmonary Function, and Respiratory Care.
Karen S. McCoy, MD, is chief of the Division of Pulmonary Medicine at Nationwide Children’s Hospital, Nationwide Foundation Endowed Chair in Pulmonary Medicine and professor of Pediatrics at The Ohio State University College of Medicine. Her clinical interests focus on managing patients of all ages with cystic fibrosis (CF) and pediatric asthma. Dr. McCoy’s research interests revolve around clinical outcomes and trials in cystic fibrosis and asthma. She is the principal investigator for the CF Therapeutic Development Center. She is the director of the CF Center, and medical director for Infant and Non-infant Pulmonary Function, and Respiratory Care.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Locations
Main Campus of Nationwide Children’s Hospital
Locations
Main Campus of Nationwide Children’s Hospital
Locations
Main Campus of Nationwide Children’s Hospital
- Main Campus of Nationwide Children’s Hospital
Academic and Clinical Areas
Cystic Fibrosis
Chief
Pulmonary Medicine
Division Chief
Advanced Lung Disease
Physician Team
Neuromuscular Disorders
Physician Team
Jeune’s Syndrome
Physician Team
Asthma Program
Physician Team
Pediatric Pulmonary Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Pulmonary, Sleep Medicine and Cystic Fibrosis
Academic and Clinical Areas
Cystic Fibrosis
Chief
Pulmonary Medicine
Division Chief
Advanced Lung Disease
Physician Team
Neuromuscular Disorders
Physician Team
Jeune’s Syndrome
Physician Team
Asthma Program
Physician Team
Pediatric Pulmonary Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Pulmonary, Sleep Medicine and Cystic Fibrosis
Academic and Clinical Areas
Cystic Fibrosis
Chief
Pulmonary Medicine
Division Chief
Advanced Lung Disease
Physician Team
Neuromuscular Disorders
Physician Team
Jeune’s Syndrome
Physician Team
Asthma Program
Physician Team
Pediatric Pulmonary Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Pulmonary, Sleep Medicine and Cystic Fibrosis
Cystic Fibrosis
Chief
Pulmonary Medicine
Division Chief
Advanced Lung Disease
Physician Team
Neuromuscular Disorders
Physician Team
Jeune’s Syndrome
Physician Team
Asthma Program
Physician Team
Pediatric Pulmonary Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Pulmonary, Sleep Medicine and Cystic Fibrosis
- Cystic Fibrosis
- Chief
- Pulmonary Medicine
- Division Chief
- Advanced Lung Disease
- Physician Team
- Neuromuscular Disorders
- Physician Team
- Jeune’s Syndrome
- Physician Team
- Asthma Program
- Physician Team
- Pediatric Pulmonary Fellowship
- Faculty
- Primary Department
- Pediatrics
- Primary Section
- Pulmonary, Sleep Medicine and Cystic Fibrosis
Awards, Honors & Organizations
Career Contribution Award Recipient, Nationwide Children’s Hospital, 2018 Golden Stethoscope Award Recipient, Nationwide Children’s Hospital, 2012 Listed, Best Doctors in America
Awards, Honors & Organizations
Career Contribution Award Recipient, Nationwide Children’s Hospital, 2018 Golden Stethoscope Award Recipient, Nationwide Children’s Hospital, 2012 Listed, Best Doctors in America
Awards, Honors & Organizations
Career Contribution Award Recipient, Nationwide Children’s Hospital, 2018 Golden Stethoscope Award Recipient, Nationwide Children’s Hospital, 2012 Listed, Best Doctors in America
Career Contribution Award Recipient, Nationwide Children’s Hospital, 2018 Golden Stethoscope Award Recipient, Nationwide Children’s Hospital, 2012 Listed, Best Doctors in America
- Career Contribution Award Recipient, Nationwide Children’s Hospital, 2018
- Golden Stethoscope Award Recipient, Nationwide Children’s Hospital, 2012
- Listed, Best Doctors in America
Research
Publications
Sheikh S, Britt RD Jr, Ryan-Wenger NA, Khan AQ, Lewis BW, Gushue C, Ozuna H, Jaganathan D, McCoy K, Kopp BT. Impact of Elexacaftor-Tezacaftor-Ivacaftor on Bacterial Colonization and Inflammatory Responses in Cystic Fibrosis. Pediatr Pulmonol. 2022 Nov 29;
Zhang S, Shrestha CL, Robledo-Avila F, Jaganathan D, Wisniewski BL, Brown N, Pham H, Carey K, Amer AO, Hall-Stoodley L, McCoy KS, Bai S, Partida-Sanchez S, Kopp BT. Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor. Eur Respir J. 2022 Oct 20;
Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;
Hall-Stoodley L, McCoy KS. Biofilm aggregates and the host airway-microbial interface. Front Cell Infect Microbiol. 2022; 12: 969326.
Huang Y, Paul G, Lee J, Yarlagadda S, McCoy K, Naren AP. Elexacaftor/Tezacaftor/Ivacaftor Improved Clinical Outcomes in a Patient with N1303K-CFTR Based on In Vitro Experimental Evidence. Am J Respir Crit Care Med. 2021 Nov 15; 204: 1231-1235.
Paul GR, Bai S, Jackson K, McCoy KS. Aquagenic wrinkling in children under two years of age: Could this be a potential clinical referral tool for cystic fibrosis among non-screened populations? J Cyst Fibros. 2021 Sep; 20: e77-e83.
Wang H, Diaz A, Moyer K, Mele-Casas M, Ara-Montojo MF, Torrus I, McCoy K, Mejias A, Leber AL. Molecular and Clinical Comparison of Enterovirus D68 Outbreaks among Hospitalized Children, Ohio, USA, 2014 and 2018. Emerg Infect Dis. 2019 Nov 17; 25:
Schuler CL, Biagini Myers JM, Kercsmar CM, Pilipenko VV, Kroner JW, Simmons JM, Austin SR, Gunkelman SM, Ross KR, McCoy KS, Kalra M, Ruddy JR, Martin LJ, Khurana Hershey GK. Weighing in on asthma: Insights on BMI, magnesium, and hospitalizations from the Ohio Pediatric Asthma Repository. J Asthma. 2019 Aug 14; 1-8.
Goetz D, Kopp BT, Salvator A, Moore-Clingenpeel M, McCoy K, Leung DH, Kloster M, Ramsey BR, Heltshe SH, Borowitz D. Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study. Pediatr Pulmonol. 2019 May; 54: 581-586.
Sagel SD, Khan U, Jain R, Graff G, Daines CL, Dunitz JM, Borowitz D, Orenstein DM, Abdulhamid I, Noe J, Clancy JP, Slovis B, Rock MJ, McCoy KS, Strausbaugh S, Livingston FR, Papas KA, Shaffer ML. Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial. Am J Respir Crit Care Med. 2018 Sep 1; 198: 639-647.
Clary G, Sasindran SJ, Nesbitt N, Mason L, Cole S, Azad A, McCoy K, Schlesinger LS, Hall-Stoodley L. Mycobacterium abscessus Smooth and Rough Morphotypes Form Antimicrobial-Tolerant Biofilm Phenotypes but Are Killed by Acetic Acid. Antimicrob Agents Chemother. 2018 Mar; 62:
Shein SL, Farhan O, Morris N, Mahmood N, Alter SJ, Biagini Myers JM, Gunkelman SM, Kercsmar CM, Khurana Hershey GK, Martin LJ, McCoy KS, Ruddy JR, Ross KR. Adjunctive Pharmacotherapies in Children With Asthma Exacerbations Requiring Continuous Albuterol Therapy: Findings From The Ohio Pediatric Asthma Repository. Hosp Pediatr. 2018 Jan 5;
View More Publications
Research
Publications
Sheikh S, Britt RD Jr, Ryan-Wenger NA, Khan AQ, Lewis BW, Gushue C, Ozuna H, Jaganathan D, McCoy K, Kopp BT. Impact of Elexacaftor-Tezacaftor-Ivacaftor on Bacterial Colonization and Inflammatory Responses in Cystic Fibrosis. Pediatr Pulmonol. 2022 Nov 29;
Zhang S, Shrestha CL, Robledo-Avila F, Jaganathan D, Wisniewski BL, Brown N, Pham H, Carey K, Amer AO, Hall-Stoodley L, McCoy KS, Bai S, Partida-Sanchez S, Kopp BT. Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor. Eur Respir J. 2022 Oct 20;
Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;
Hall-Stoodley L, McCoy KS. Biofilm aggregates and the host airway-microbial interface. Front Cell Infect Microbiol. 2022; 12: 969326.
Huang Y, Paul G, Lee J, Yarlagadda S, McCoy K, Naren AP. Elexacaftor/Tezacaftor/Ivacaftor Improved Clinical Outcomes in a Patient with N1303K-CFTR Based on In Vitro Experimental Evidence. Am J Respir Crit Care Med. 2021 Nov 15; 204: 1231-1235.
Paul GR, Bai S, Jackson K, McCoy KS. Aquagenic wrinkling in children under two years of age: Could this be a potential clinical referral tool for cystic fibrosis among non-screened populations? J Cyst Fibros. 2021 Sep; 20: e77-e83.
Wang H, Diaz A, Moyer K, Mele-Casas M, Ara-Montojo MF, Torrus I, McCoy K, Mejias A, Leber AL. Molecular and Clinical Comparison of Enterovirus D68 Outbreaks among Hospitalized Children, Ohio, USA, 2014 and 2018. Emerg Infect Dis. 2019 Nov 17; 25:
Schuler CL, Biagini Myers JM, Kercsmar CM, Pilipenko VV, Kroner JW, Simmons JM, Austin SR, Gunkelman SM, Ross KR, McCoy KS, Kalra M, Ruddy JR, Martin LJ, Khurana Hershey GK. Weighing in on asthma: Insights on BMI, magnesium, and hospitalizations from the Ohio Pediatric Asthma Repository. J Asthma. 2019 Aug 14; 1-8.
Goetz D, Kopp BT, Salvator A, Moore-Clingenpeel M, McCoy K, Leung DH, Kloster M, Ramsey BR, Heltshe SH, Borowitz D. Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study. Pediatr Pulmonol. 2019 May; 54: 581-586.
Sagel SD, Khan U, Jain R, Graff G, Daines CL, Dunitz JM, Borowitz D, Orenstein DM, Abdulhamid I, Noe J, Clancy JP, Slovis B, Rock MJ, McCoy KS, Strausbaugh S, Livingston FR, Papas KA, Shaffer ML. Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial. Am J Respir Crit Care Med. 2018 Sep 1; 198: 639-647.
Clary G, Sasindran SJ, Nesbitt N, Mason L, Cole S, Azad A, McCoy K, Schlesinger LS, Hall-Stoodley L. Mycobacterium abscessus Smooth and Rough Morphotypes Form Antimicrobial-Tolerant Biofilm Phenotypes but Are Killed by Acetic Acid. Antimicrob Agents Chemother. 2018 Mar; 62:
Shein SL, Farhan O, Morris N, Mahmood N, Alter SJ, Biagini Myers JM, Gunkelman SM, Kercsmar CM, Khurana Hershey GK, Martin LJ, McCoy KS, Ruddy JR, Ross KR. Adjunctive Pharmacotherapies in Children With Asthma Exacerbations Requiring Continuous Albuterol Therapy: Findings From The Ohio Pediatric Asthma Repository. Hosp Pediatr. 2018 Jan 5;
View More Publications
Research
Publications
Sheikh S, Britt RD Jr, Ryan-Wenger NA, Khan AQ, Lewis BW, Gushue C, Ozuna H, Jaganathan D, McCoy K, Kopp BT. Impact of Elexacaftor-Tezacaftor-Ivacaftor on Bacterial Colonization and Inflammatory Responses in Cystic Fibrosis. Pediatr Pulmonol. 2022 Nov 29;
Zhang S, Shrestha CL, Robledo-Avila F, Jaganathan D, Wisniewski BL, Brown N, Pham H, Carey K, Amer AO, Hall-Stoodley L, McCoy KS, Bai S, Partida-Sanchez S, Kopp BT. Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor. Eur Respir J. 2022 Oct 20;
Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;
Hall-Stoodley L, McCoy KS. Biofilm aggregates and the host airway-microbial interface. Front Cell Infect Microbiol. 2022; 12: 969326.
Huang Y, Paul G, Lee J, Yarlagadda S, McCoy K, Naren AP. Elexacaftor/Tezacaftor/Ivacaftor Improved Clinical Outcomes in a Patient with N1303K-CFTR Based on In Vitro Experimental Evidence. Am J Respir Crit Care Med. 2021 Nov 15; 204: 1231-1235.
Paul GR, Bai S, Jackson K, McCoy KS. Aquagenic wrinkling in children under two years of age: Could this be a potential clinical referral tool for cystic fibrosis among non-screened populations? J Cyst Fibros. 2021 Sep; 20: e77-e83.
Wang H, Diaz A, Moyer K, Mele-Casas M, Ara-Montojo MF, Torrus I, McCoy K, Mejias A, Leber AL. Molecular and Clinical Comparison of Enterovirus D68 Outbreaks among Hospitalized Children, Ohio, USA, 2014 and 2018. Emerg Infect Dis. 2019 Nov 17; 25:
Schuler CL, Biagini Myers JM, Kercsmar CM, Pilipenko VV, Kroner JW, Simmons JM, Austin SR, Gunkelman SM, Ross KR, McCoy KS, Kalra M, Ruddy JR, Martin LJ, Khurana Hershey GK. Weighing in on asthma: Insights on BMI, magnesium, and hospitalizations from the Ohio Pediatric Asthma Repository. J Asthma. 2019 Aug 14; 1-8.
Goetz D, Kopp BT, Salvator A, Moore-Clingenpeel M, McCoy K, Leung DH, Kloster M, Ramsey BR, Heltshe SH, Borowitz D. Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study. Pediatr Pulmonol. 2019 May; 54: 581-586.
Sagel SD, Khan U, Jain R, Graff G, Daines CL, Dunitz JM, Borowitz D, Orenstein DM, Abdulhamid I, Noe J, Clancy JP, Slovis B, Rock MJ, McCoy KS, Strausbaugh S, Livingston FR, Papas KA, Shaffer ML. Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial. Am J Respir Crit Care Med. 2018 Sep 1; 198: 639-647.
Clary G, Sasindran SJ, Nesbitt N, Mason L, Cole S, Azad A, McCoy K, Schlesinger LS, Hall-Stoodley L. Mycobacterium abscessus Smooth and Rough Morphotypes Form Antimicrobial-Tolerant Biofilm Phenotypes but Are Killed by Acetic Acid. Antimicrob Agents Chemother. 2018 Mar; 62:
Shein SL, Farhan O, Morris N, Mahmood N, Alter SJ, Biagini Myers JM, Gunkelman SM, Kercsmar CM, Khurana Hershey GK, Martin LJ, McCoy KS, Ruddy JR, Ross KR. Adjunctive Pharmacotherapies in Children With Asthma Exacerbations Requiring Continuous Albuterol Therapy: Findings From The Ohio Pediatric Asthma Repository. Hosp Pediatr. 2018 Jan 5;
View More Publications
Publications
Sheikh S, Britt RD Jr, Ryan-Wenger NA, Khan AQ, Lewis BW, Gushue C, Ozuna H, Jaganathan D, McCoy K, Kopp BT. Impact of Elexacaftor-Tezacaftor-Ivacaftor on Bacterial Colonization and Inflammatory Responses in Cystic Fibrosis. Pediatr Pulmonol. 2022 Nov 29;
Zhang S, Shrestha CL, Robledo-Avila F, Jaganathan D, Wisniewski BL, Brown N, Pham H, Carey K, Amer AO, Hall-Stoodley L, McCoy KS, Bai S, Partida-Sanchez S, Kopp BT. Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor. Eur Respir J. 2022 Oct 20;
Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;
Hall-Stoodley L, McCoy KS. Biofilm aggregates and the host airway-microbial interface. Front Cell Infect Microbiol. 2022; 12: 969326.
Huang Y, Paul G, Lee J, Yarlagadda S, McCoy K, Naren AP. Elexacaftor/Tezacaftor/Ivacaftor Improved Clinical Outcomes in a Patient with N1303K-CFTR Based on In Vitro Experimental Evidence. Am J Respir Crit Care Med. 2021 Nov 15; 204: 1231-1235.
Paul GR, Bai S, Jackson K, McCoy KS. Aquagenic wrinkling in children under two years of age: Could this be a potential clinical referral tool for cystic fibrosis among non-screened populations? J Cyst Fibros. 2021 Sep; 20: e77-e83.
Wang H, Diaz A, Moyer K, Mele-Casas M, Ara-Montojo MF, Torrus I, McCoy K, Mejias A, Leber AL. Molecular and Clinical Comparison of Enterovirus D68 Outbreaks among Hospitalized Children, Ohio, USA, 2014 and 2018. Emerg Infect Dis. 2019 Nov 17; 25:
Schuler CL, Biagini Myers JM, Kercsmar CM, Pilipenko VV, Kroner JW, Simmons JM, Austin SR, Gunkelman SM, Ross KR, McCoy KS, Kalra M, Ruddy JR, Martin LJ, Khurana Hershey GK. Weighing in on asthma: Insights on BMI, magnesium, and hospitalizations from the Ohio Pediatric Asthma Repository. J Asthma. 2019 Aug 14; 1-8.
Goetz D, Kopp BT, Salvator A, Moore-Clingenpeel M, McCoy K, Leung DH, Kloster M, Ramsey BR, Heltshe SH, Borowitz D. Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study. Pediatr Pulmonol. 2019 May; 54: 581-586.
Sagel SD, Khan U, Jain R, Graff G, Daines CL, Dunitz JM, Borowitz D, Orenstein DM, Abdulhamid I, Noe J, Clancy JP, Slovis B, Rock MJ, McCoy KS, Strausbaugh S, Livingston FR, Papas KA, Shaffer ML. Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial. Am J Respir Crit Care Med. 2018 Sep 1; 198: 639-647.
Clary G, Sasindran SJ, Nesbitt N, Mason L, Cole S, Azad A, McCoy K, Schlesinger LS, Hall-Stoodley L. Mycobacterium abscessus Smooth and Rough Morphotypes Form Antimicrobial-Tolerant Biofilm Phenotypes but Are Killed by Acetic Acid. Antimicrob Agents Chemother. 2018 Mar; 62:
Shein SL, Farhan O, Morris N, Mahmood N, Alter SJ, Biagini Myers JM, Gunkelman SM, Kercsmar CM, Khurana Hershey GK, Martin LJ, McCoy KS, Ruddy JR, Ross KR. Adjunctive Pharmacotherapies in Children With Asthma Exacerbations Requiring Continuous Albuterol Therapy: Findings From The Ohio Pediatric Asthma Repository. Hosp Pediatr. 2018 Jan 5;
View More Publications
Sheikh S, Britt RD Jr, Ryan-Wenger NA, Khan AQ, Lewis BW, Gushue C, Ozuna H, Jaganathan D, McCoy K, Kopp BT. Impact of Elexacaftor-Tezacaftor-Ivacaftor on Bacterial Colonization and Inflammatory Responses in Cystic Fibrosis. Pediatr Pulmonol. 2022 Nov 29;
Zhang S, Shrestha CL, Robledo-Avila F, Jaganathan D, Wisniewski BL, Brown N, Pham H, Carey K, Amer AO, Hall-Stoodley L, McCoy KS, Bai S, Partida-Sanchez S, Kopp BT. Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor. Eur Respir J. 2022 Oct 20;
Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;
Hall-Stoodley L, McCoy KS. Biofilm aggregates and the host airway-microbial interface. Front Cell Infect Microbiol. 2022; 12: 969326.
Huang Y, Paul G, Lee J, Yarlagadda S, McCoy K, Naren AP. Elexacaftor/Tezacaftor/Ivacaftor Improved Clinical Outcomes in a Patient with N1303K-CFTR Based on In Vitro Experimental Evidence. Am J Respir Crit Care Med. 2021 Nov 15; 204: 1231-1235.
Paul GR, Bai S, Jackson K, McCoy KS. Aquagenic wrinkling in children under two years of age: Could this be a potential clinical referral tool for cystic fibrosis among non-screened populations? J Cyst Fibros. 2021 Sep; 20: e77-e83.
Wang H, Diaz A, Moyer K, Mele-Casas M, Ara-Montojo MF, Torrus I, McCoy K, Mejias A, Leber AL. Molecular and Clinical Comparison of Enterovirus D68 Outbreaks among Hospitalized Children, Ohio, USA, 2014 and 2018. Emerg Infect Dis. 2019 Nov 17; 25:
Schuler CL, Biagini Myers JM, Kercsmar CM, Pilipenko VV, Kroner JW, Simmons JM, Austin SR, Gunkelman SM, Ross KR, McCoy KS, Kalra M, Ruddy JR, Martin LJ, Khurana Hershey GK. Weighing in on asthma: Insights on BMI, magnesium, and hospitalizations from the Ohio Pediatric Asthma Repository. J Asthma. 2019 Aug 14; 1-8.
Goetz D, Kopp BT, Salvator A, Moore-Clingenpeel M, McCoy K, Leung DH, Kloster M, Ramsey BR, Heltshe SH, Borowitz D. Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study. Pediatr Pulmonol. 2019 May; 54: 581-586.
Sagel SD, Khan U, Jain R, Graff G, Daines CL, Dunitz JM, Borowitz D, Orenstein DM, Abdulhamid I, Noe J, Clancy JP, Slovis B, Rock MJ, McCoy KS, Strausbaugh S, Livingston FR, Papas KA, Shaffer ML. Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial. Am J Respir Crit Care Med. 2018 Sep 1; 198: 639-647.
Clary G, Sasindran SJ, Nesbitt N, Mason L, Cole S, Azad A, McCoy K, Schlesinger LS, Hall-Stoodley L. Mycobacterium abscessus Smooth and Rough Morphotypes Form Antimicrobial-Tolerant Biofilm Phenotypes but Are Killed by Acetic Acid. Antimicrob Agents Chemother. 2018 Mar; 62:
Shein SL, Farhan O, Morris N, Mahmood N, Alter SJ, Biagini Myers JM, Gunkelman SM, Kercsmar CM, Khurana Hershey GK, Martin LJ, McCoy KS, Ruddy JR, Ross KR. Adjunctive Pharmacotherapies in Children With Asthma Exacerbations Requiring Continuous Albuterol Therapy: Findings From The Ohio Pediatric Asthma Repository. Hosp Pediatr. 2018 Jan 5;
View More Publications
- Sheikh S, Britt RD Jr, Ryan-Wenger NA, Khan AQ, Lewis BW, Gushue C, Ozuna H, Jaganathan D, McCoy K, Kopp BT. Impact of Elexacaftor-Tezacaftor-Ivacaftor on Bacterial Colonization and Inflammatory Responses in Cystic Fibrosis. Pediatr Pulmonol. 2022 Nov 29;
- Zhang S, Shrestha CL, Robledo-Avila F, Jaganathan D, Wisniewski BL, Brown N, Pham H, Carey K, Amer AO, Hall-Stoodley L, McCoy KS, Bai S, Partida-Sanchez S, Kopp BT. Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor. Eur Respir J. 2022 Oct 20;
- Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;
- Hall-Stoodley L, McCoy KS. Biofilm aggregates and the host airway-microbial interface. Front Cell Infect Microbiol. 2022; 12: 969326.
- Huang Y, Paul G, Lee J, Yarlagadda S, McCoy K, Naren AP. Elexacaftor/Tezacaftor/Ivacaftor Improved Clinical Outcomes in a Patient with N1303K-CFTR Based on In Vitro Experimental Evidence. Am J Respir Crit Care Med. 2021 Nov 15; 204: 1231-1235.
- Paul GR, Bai S, Jackson K, McCoy KS. Aquagenic wrinkling in children under two years of age: Could this be a potential clinical referral tool for cystic fibrosis among non-screened populations? J Cyst Fibros. 2021 Sep; 20: e77-e83.
- Wang H, Diaz A, Moyer K, Mele-Casas M, Ara-Montojo MF, Torrus I, McCoy K, Mejias A, Leber AL. Molecular and Clinical Comparison of Enterovirus D68 Outbreaks among Hospitalized Children, Ohio, USA, 2014 and 2018. Emerg Infect Dis. 2019 Nov 17; 25:
- Schuler CL, Biagini Myers JM, Kercsmar CM, Pilipenko VV, Kroner JW, Simmons JM, Austin SR, Gunkelman SM, Ross KR, McCoy KS, Kalra M, Ruddy JR, Martin LJ, Khurana Hershey GK. Weighing in on asthma: Insights on BMI, magnesium, and hospitalizations from the Ohio Pediatric Asthma Repository. J Asthma. 2019 Aug 14; 1-8.
- Goetz D, Kopp BT, Salvator A, Moore-Clingenpeel M, McCoy K, Leung DH, Kloster M, Ramsey BR, Heltshe SH, Borowitz D. Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study. Pediatr Pulmonol. 2019 May; 54: 581-586.
- Sagel SD, Khan U, Jain R, Graff G, Daines CL, Dunitz JM, Borowitz D, Orenstein DM, Abdulhamid I, Noe J, Clancy JP, Slovis B, Rock MJ, McCoy KS, Strausbaugh S, Livingston FR, Papas KA, Shaffer ML. Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial. Am J Respir Crit Care Med. 2018 Sep 1; 198: 639-647.
- Clary G, Sasindran SJ, Nesbitt N, Mason L, Cole S, Azad A, McCoy K, Schlesinger LS, Hall-Stoodley L. Mycobacterium abscessus Smooth and Rough Morphotypes Form Antimicrobial-Tolerant Biofilm Phenotypes but Are Killed by Acetic Acid. Antimicrob Agents Chemother. 2018 Mar; 62:
- Shein SL, Farhan O, Morris N, Mahmood N, Alter SJ, Biagini Myers JM, Gunkelman SM, Kercsmar CM, Khurana Hershey GK, Martin LJ, McCoy KS, Ruddy JR, Ross KR. Adjunctive Pharmacotherapies in Children With Asthma Exacerbations Requiring Continuous Albuterol Therapy: Findings From The Ohio Pediatric Asthma Repository. Hosp Pediatr. 2018 Jan 5;
Education
Date of Appointment at Nationwide Children’s Hospital: 02/16/1988
Board Certifications
Pediatric Pulmonary Medicine Pediatrics
Fellowship
Arizona Health Science Center
Date Completed: 06/30/1982
Residency
North Carolina Memorial Hospital
Date Completed: 06/30/1979
Medical School
University of North Carolina
Date Completed: 12/31/1975
Education
Date of Appointment at Nationwide Children’s Hospital: 02/16/1988
Board Certifications
Pediatric Pulmonary Medicine Pediatrics
Fellowship
Arizona Health Science Center
Date Completed: 06/30/1982
Residency
North Carolina Memorial Hospital
Date Completed: 06/30/1979
Medical School
University of North Carolina
Date Completed: 12/31/1975
Education
Date of Appointment at Nationwide Children’s Hospital: 02/16/1988
Board Certifications
Pediatric Pulmonary Medicine Pediatrics
Fellowship
Arizona Health Science Center
Date Completed: 06/30/1982
Residency
North Carolina Memorial Hospital
Date Completed: 06/30/1979
Medical School
University of North Carolina
Date Completed: 12/31/1975
Date of Appointment at Nationwide Children’s Hospital: 02/16/1988
Board Certifications
Pediatric Pulmonary Medicine Pediatrics
Fellowship
Arizona Health Science Center
Date Completed: 06/30/1982
Residency
North Carolina Memorial Hospital
Date Completed: 06/30/1979
Medical School
University of North Carolina
Date Completed: 12/31/1975
Date of Appointment at Nationwide Children’s Hospital: 02/16/1988
Board Certifications
Pediatric Pulmonary Medicine Pediatrics
Fellowship
Arizona Health Science Center
Date Completed: 06/30/1982
Residency
North Carolina Memorial Hospital
Date Completed: 06/30/1979
Medical School
University of North Carolina
Date Completed: 12/31/1975
- Pediatric Pulmonary Medicine
- Pediatrics
Professional Experience
1995 - Present Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children’s Hospita, Associate Professor of Pediatrics1987 - 1995 Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children’s Hospital, Asst. Prof Pediatrics1985 - 1987 Division of Pulmonary Disease/Cystic Fibrosis Regional Center, University of Florida College of Medicine, Asst. Prof Pediatrics1982 - 1984 OSU College of Medicine and Medical Director of Respiratory Care and Pulmonary Functions, Children’s Hospital, Asst. Prof Pediatrics1979 - 1982 Arizona Health Science Center, Fellowship Ped. Pulmonary Disease1977 - 1979 NC Memorial Hospital, Residency Pediatrics1976 - 1977 NC Memorial Hospital, Internship Pediatrics
Professional Experience
1995 - Present Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children’s Hospita, Associate Professor of Pediatrics1987 - 1995 Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children’s Hospital, Asst. Prof Pediatrics1985 - 1987 Division of Pulmonary Disease/Cystic Fibrosis Regional Center, University of Florida College of Medicine, Asst. Prof Pediatrics1982 - 1984 OSU College of Medicine and Medical Director of Respiratory Care and Pulmonary Functions, Children’s Hospital, Asst. Prof Pediatrics1979 - 1982 Arizona Health Science Center, Fellowship Ped. Pulmonary Disease1977 - 1979 NC Memorial Hospital, Residency Pediatrics1976 - 1977 NC Memorial Hospital, Internship Pediatrics
Professional Experience
1995 - Present Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children’s Hospita, Associate Professor of Pediatrics1987 - 1995 Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children’s Hospital, Asst. Prof Pediatrics1985 - 1987 Division of Pulmonary Disease/Cystic Fibrosis Regional Center, University of Florida College of Medicine, Asst. Prof Pediatrics1982 - 1984 OSU College of Medicine and Medical Director of Respiratory Care and Pulmonary Functions, Children’s Hospital, Asst. Prof Pediatrics1979 - 1982 Arizona Health Science Center, Fellowship Ped. Pulmonary Disease1977 - 1979 NC Memorial Hospital, Residency Pediatrics1976 - 1977 NC Memorial Hospital, Internship Pediatrics
1995 - Present Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children’s Hospita, Associate Professor of Pediatrics1987 - 1995 Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children’s Hospital, Asst. Prof Pediatrics1985 - 1987 Division of Pulmonary Disease/Cystic Fibrosis Regional Center, University of Florida College of Medicine, Asst. Prof Pediatrics1982 - 1984 OSU College of Medicine and Medical Director of Respiratory Care and Pulmonary Functions, Children’s Hospital, Asst. Prof Pediatrics1979 - 1982 Arizona Health Science Center, Fellowship Ped. Pulmonary Disease1977 - 1979 NC Memorial Hospital, Residency Pediatrics1976 - 1977 NC Memorial Hospital, Internship Pediatrics
1995 - Present Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children’s Hospita, Associate Professor of Pediatrics
Contact Information
Pediatrics
Call us at: (614) 722-4766
Fax us at: (614) 722-4755
Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-4766
Fax us at: (614) 722-4755
Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-4766
Fax us at: (614) 722-4755
Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)
Pediatrics
Call us at: (614) 722-4766
Fax us at: (614) 722-4755
Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-4766
Fax us at: (614) 722-4755
Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-4766
Fax us at: (614) 722-4755
Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)
- Call us at:
- (614) 722-4766
- Fax us at:
- (614) 722-4755
- Pulmonary Medicine700 Children’s DrColumbus, OH 43205 (map)
